Keyphrases
Antibiotics
100%
Drug Combination
100%
Mycobacterium Abscessus
100%
FoF1-ATP Synthase
54%
Oxidative Phosphorylation (OXPHOS)
18%
Oxidase
18%
Multidrug-resistant
18%
Synergistic Efficacy
9%
Multidrug Combination
9%
Hit Identification
9%
Target Identification
9%
Lead Molecules
9%
Preclinical Development
9%
Antimycobacterial Activity
9%
Oxidative Phosphorylation Pathway
9%
Potential Drugs
9%
Enzyme Inhibition
9%
Hit Molecules
9%
Key Amino Acids
9%
ATP Synthase
9%
Mycobacterium Tuberculosis (M. tb)
9%
Latency
9%
Mechanistic Insight
9%
Catheter-related Infections
9%
Drug Target
9%
Shine
9%
Cryo-EM Structure
9%
Nontuberculous Mycobacterial Infection
9%
Structural Insights
9%
Compound Target
9%
ATP Synthesis
9%
ATPase Inhibitor
9%
Enzyme Complex
9%
Singapore
9%
Pulmonary Disease
9%
Mechanistic Aspects
9%
Solution Structure
9%
Atomic Solution
9%
F1-ATPase
9%
ATP Hydrolysis
9%
Epitope
9%
Pharmacology, Toxicology and Pharmaceutical Science
Mycobacterium abscessus
100%
Nightmare
100%
Combination Drug
100%
Adenosine Triphosphate
90%
Synthetase
54%
Infectious Agent
27%
Oxidoreductase
18%
Catheter Infection
9%
Drug Delivery System
9%
Prevalence
9%
Proton Transporting Adenosine Triphosphate Synthase
9%
Cryo-Electron Microscopy
9%
Epitope
9%
Infection
9%
Enzyme Inhibition
9%
Amino Acid
9%
Lung Disease
9%
Biochemistry, Genetics and Molecular Biology
Nightmare
100%
Mycobacterium abscessus
100%
ATP Synthase
54%
Adenosine Triphosphate
36%
Oxidative Phosphorylation
27%
Infectious Agent
27%
Oxidase
18%
Oxidoreductase
18%
Enzyme
9%
Amino Acids
9%
Preclinical Study
9%
Solution and Solubility
9%
Cryoelectron Microscopy
9%
Prevalence
9%
Drug Targeting
9%
V-ATPase
9%
Enzymatic Hydrolysis
9%
Enzyme Inhibition
9%